Malignant potential of skull base versus non-skull base meningiomas: Clinical series of 1,663 cases

Acta Neurochirurgica

Volumn 155, Issue 3, 2013, Pages 407-413

  Cornelius, Jan Frederick ^a   Slotty, Philipp Jörg ^a   Steiger, Hans Jakob ^a   Hänggi, Daniel ^a   Polivka, Marc ^b   George, Bernard ^b  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Localisation; Meningioma; Risk factor; Skull base; WHO grade

Indexed keywords

KI 67 ANTIGEN;

AGE; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER LOCALIZATION; CANCER PATIENT; CASE STUDY; CONTROLLED STUDY; FEMALE; GENDER; HEALTH SURVEY; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT MENINGIOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX; SKULL BASE TUMOR; WORLD HEALTH ORGANIZATION;

ADULT; AGE FACTORS; AGED; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KI-67 ANTIGEN; MAGNETIC RESONANCE IMAGING; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SKULL BASE NEOPLASMS;

EID: 84878404452     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-012-1611-y     Document Type: Article

References (32)

1. Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL, Curry WT Jr, Barker FG 2nd (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64:56-60, discussion 60
2. Buccoliero AM, Castiglione F, Degl'Innocenti DR, Gheri CF, Garbini F, Taddei A, Ammannati F, Mennonna P, Taddei GL (2007) NF2 gene expression in sporadic meningiomas: relation to grades or histotypes real time-pCR study. Neuropathology 27:36-42
3. Cea-Soriano L, Blenk T, Wallander MA, Rodriguez LA (2011) Hormonal therapies and meningioma: is there a link? Cancer Epidemiol 36:198-205
4. Chamberlain MC, Barnholtz-Sloan JS (2011) Medical treatment of recurrent meningiomas. Expert Rev Neurother 11:1425-1432
5. Chamberlain MC, Glantz MJ (2008) Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas. Cancer 113:2146-2151
6. Cornelius JF, Langen KJ, Stoffels G, Hanggi D, Sabel M, Steiger HJ (2012) PET imaging of meningioma in clinical practice: review of literature and future directions. Neurosurgery 70(4):1033-1041, discussion 1042
7. Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamarides M, Menei P, Deruty R, Moreau JJ, Fevre-Montange M, Guyotat J (2009) WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 95:367-375
8. Engenhart-Cabillic R, Farhoud A, Sure U, Heinze S, Henzel M, Mennel HD, Bertalanffy H (2006) Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment. Strahlenther Onkol 182:641-646
9. Jaaskelainen J, Haltia M, Servo A (1986) Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25:233-242
10. Kalamarides M, Stemmer-Rachamimov AO, Niwa-Kawakita M, Chareyre F, Taranchon E, Han ZY, Martinelli C, Lusis EA, Hegedus B, Gutmann DH, Giovannini M (2011) Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes. Oncogene 30:2333-2344
11. Kane AJ, Sughrue ME, Rutkowski MJ, Shangari G, Fang S, McDermott MW, Berger MS, Parsa AT (2011) Anatomic location is a risk factor for atypical and malignant meningiomas. Cancer 117:1272-1278
12. Kasuya H, Kubo O, Tanaka M, Amano K, Kato K, Hori T (2006) Clinical and radiological features related to the growth potential of meningioma. Neurosurg Rev 29:293-296, discussion 296-297
13. Keller A, Ludwig N, Comtesse N, Hildebrandt A, Meese E, Lenhof HP (2006) A minimally invasive multiple marker approach allows highly efficient detection of meningioma tumors. BMC Bioinforma 7:539
14. Kim DG, Kim Ch H, Chung HT, Paek SH, Jeong SS, Han DH, Jung HW (2005) Gamma knife surgery of superficially located meningioma. J Neurosurg 102(Suppl):255-258
15. Kleihues P, Sobin LH (2000) World Health Organization classification of tumors. Cancer 88:2887
16. Kollova A, Liscak R, Novotny J Jr, Vladyka V, Simonova G, Janouskova L (2007) Gamma Knife surgery for benign meningioma. J Neurosurg 107:325-336
17. Korhonen K, Raitanen J, Isola J, Haapasalo H, Salminen T, Auvinen A (2010) Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland. Cancer Causes Control 21:2149-2156
18. Lohmann CM, Brat DJ (2000) A conceptual shift in the grading of meningiomas. Adv Anat Pathol 7:153-157
19. Ludwig N, Keller A, Heisel S, Leidinger P, Rheinheimer S, Andres C, Stephan B, Steudel WI, Donauer E, Graf N, Burgeth B, Weickert J, Lenhof HP, Meese E (2011) Novel immunogenic antigens increase classification accuracy in meningioma to 93.84 %. Int J Cancer 128:1493-1501
20. McGovern SL, Aldape KD, Munsell MF, Mahajan A, DeMonte F, Woo SY (2010) A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas. J Neurosurg 112:925-933
21. Michaud DS, Gallo V, Schlehofer B, Tjonneland A, Olsen A, Overvad K, Dahm CC, Kaaks R, Lukanova A, Boeing H, Schutze M, Trichopoulou A, Bamia C, Kyrozis A, Sacerdote C, Agnoli C, Palli D, Tumino R, Mattiello A, Bueno-de-Mesquita HB, Ros MM, Peeters PH, van Gils CH, Lund E, Bakken K, Gram IT, Barricarte A, Navarro C, Dorronsoro M, Sanchez MJ, Rodriguez L, Duell EJ, Hallmans G, Melin BS, Manjer J, Borgquist S, Khaw KT, Wareham N, Allen NE, Tsilidis KK, Romieu I, Rinaldi S, Vineis P, Riboli E (2010) Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev 19:2562-2569
22. Milker-Zabel S, Zabel-du Bois A, Huber P, Schlegel W, Debus J (2007) Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution. Int J Radiat Oncol Biol Phys 68:858-863
23. Modha A, Gutin PH (2005) Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 57:538-550, discussion 538-550
24. Moradi A, Semnani V, Djam H, Tajodini A, Zali AR, Ghaemi K, Nikzad N, Madani-Civi M (2008) Pathodiagnostic parameters for meningioma grading. J Clin Neurosci 15:1370-1375
25. Nakasu S, Nakasu Y, Nakajima M, Matsuda M, Handa J (1999) Preoperative identification of meningiomas that are highly likely to recur. J Neurosurg 90:455-462
26. Riemenschneider MJ, Perry A, Reifenberger G (2006) Histological classification and molecular genetics of meningiomas. Lancet Neurol 5:1045-1054
27. Sade B, Chahlavi A, Krishnaney A, Nagel S, Choi E, Lee JH (2007) World Health Organization Grades II and III meningiomas are rare in the cranial base and spine. Neurosurgery 61:1194-1198, discussion 1198
28. Sioka C, Kyritsis AP (2009) Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas. J Neurooncol 92:1-6
29. van Nieuwenhuizen D, Klein M, Stalpers LJ, Leenstra S, Heimans JJ, Reijneveld JC (2007) Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients. J Neurooncol 84:271-278
30. van Tilborg AA, Morolli B, Giphart-Gassler M, de Vries A, van Geenen DA, Lurkin I, Kros JM, Zwarthoff EC (2006) Lack of genetic and epigenetic changes in meningiomas without NF2 loss. J Pathol 208:564-573
31. Whittle IR, Smith C, Navoo P, Collie D (2004) Meningiomas. Lancet 363:1535-1543
32. Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99:307-314